SEC Form 4 · accession 0001104659-15-013140
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan M Peacock
Officer — President and CEO · Director
Period of report
Feb 19, 2015
Accepted (ET)
Feb 23, 2015 · 9:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2015 | P | 20,800 | $12.00 | A | 20,867 | D |
Table II — derivative securities
No Table II lines on this filing.